Armata Pharmaceuticals, Inc. (ARMP) stock
ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$3.03+0.05 (+1.68%)
Close on Nov 20, 2026Market cap $112.66MP/E –Yield –
Armata Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2014 it was $409.00K, up 404.9% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $409.00K | +404.9% |
| FY2013 | Dec 31, 2013 | $81.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2020 | Jun 30, 2020 | $31.00K | – |
See a number that looks wrong?